{"id":16,"date":"2021-05-23T09:30:09","date_gmt":"2021-05-23T09:30:09","guid":{"rendered":"http:\/\/eurosoi.org\/?p=16"},"modified":"2021-05-23T09:30:09","modified_gmt":"2021-05-23T09:30:09","slug":"%ef%bb%bfsupplementary-materialsfigure-1source-data-1-features-and-phenotypes-from-the-enrolled-charge-individuals-and-uncooked-data-and-statistical-data-of-shape-1","status":"publish","type":"post","link":"https:\/\/eurosoi.org\/?p=16","title":{"rendered":"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1"},"content":{"rendered":"<p>\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1. health supplement 1A. Tabs2: Statistical data of Shape 3figure health supplement 1B. elife-21114-fig3-figsupp1-data1.xlsx (39K) DOI:?10.7554\/eLife.21114.010 Figure 4source data 1: Natural data and statistical data of Figure 4. Tabs 1: Statistical data of Shape 4C.?a. Statistical data of Shape 4C (remaining). Control (WD39): t?=?0 vs t?=?8 hr. b. Statistical data of Shape 4C (correct). CHARGE (CH1#25): t?=?0 vs t?=?8 hr. c. Statistical data of Shape 4C (remaining and correct). Tabs 2: Statistical data of Shape 4D. Tabs 3: Statistical data of Shape 4F. Tabs 4: Natural data of Shape 4F. N: the amount of neighbouring cells attached using the nine outermost cells in each one of the eight 45 degree-sector of the sphere. White colored columns display the real amount of N?=?0, 1, or? 1 cells per sphere. elife-21114-fig4-data1.xlsx (60K) DOI:?10.7554\/eLife.21114.012 Figure 5source data 1: Natural data of xCelligence assay of iPSC-NCCs in vitro. Tabs &#8216;Test 1&#8217; &#8211; &#8216;Test 13&#8217;: Uncooked data of migration indexes in each test. Each table inside a sheet displays an independent test. Orange column displays migration index at 20 hr, and can be used for quantitative evaluation in Shape 5C. Tabs 1: Statistical data of Shape 5C. Quantitative evaluation of migration index after 20 hr of monitoring with xCELLigence, normalized towards the control iPSC-NCCs migration index. Tabs 2: Uncooked data and statistical data of Shape 5figure health supplement 1A. Control iPSC-NCCs migration index upon treatment with automobile or aphidicolin for 36 hr. Tabs 3: Uncooked data and statistical data of Shape 5figure health supplement 1B. BrdU assay of CHARGE and control iPSC-NCCs at 24 hr following replating. Tabs 4: Natural data and statistical data of Shape 5figure health supplement 1C. Cell adhesion assay of CHARGE and control Monoisobutyl phthalic acid iPSC-NCCs to fibronectin. elife-21114-fig5-data1.xlsx (268K) DOI:?10.7554\/eLife.21114.017 Shape 6source data 1: Natural data and statistical data of Shape 6 Tabs 1: Statistical data of Shape 6B.?Typical velocities of migratory iPSC-NCCs assessed by monitoring CHARGE and control iPSC-NCCs for <a href=\"https:\/\/www.adooq.com\/monoisobutyl-phthalic-acid.html\">Monoisobutyl phthalic acid<\/a> 16 hr. Tabs 2: Uncooked data of solitary cell motility evaluation of Monoisobutyl phthalic acid iPSCs-NCCs in vitro. Quantitative evaluation in Shape 6B was determined utilizing the data below. Tabs 3: Statistical data of Shape 6C. Tabs 4: Natural data of solitary cell motility evaluation of iPSCs-NCCs in vitro. Quantitative evaluation in Shape 6C was determined utilizing the data below. elife-21114-fig6-data1.xlsx (349K) DOI:?10.7554\/eLife.21114.021 Shape 6figure health supplement 1source data 1: Natural data and statistical data <a href=\"http:\/\/news.bbc.co.uk\/hi\/spanish\/latin_america\/newsid_7827000\/7827270.stm\">YWHAS<\/a> of Shape 6figure health supplement 1. Tabs 1: Statistical data of Shape 6figure health supplement 1A.?Typical velocities of migratory iPSC-NCCs assessed by monitoring CHARGE and control iPSC-NCCs more than 16 hr. Tabs 2: Uncooked data of solitary cell motility evaluation of iPSCs-NCCs in vitro. Quantitative evaluation in Shape 6figure health supplement 1A was determined utilizing the data below. Tabs 3: Statistical data of Shape 6figure health supplement 1B. Quantitative evaluation from the directionality of migratory iPSC-NCCs monitored. Tabs 4: Natural data of solitary cell motility evaluation of iPSCs-NCCs in vitro. Quantitative evaluation in Shape 6figure health supplement 1B was determined utilizing the data below. elife-21114-fig6-figsupp1-data1.xlsx (284K) DOI:?10.7554\/eLife.21114.020 Shape 7source data 1: A summary of transplanted cells and ratings. Tabs 1: A summary of transplanted cells and ratings.?Detais from the graph in Shape 7C. Transplanted CHARGE and control cells had been stained with Vybrant DiI or DiO. We transplanted iPSC-NCCs into 93 embryos (HH8-10) altogether, and 17 making it through embryoswere analyzed with this assay. Assessment of the utmost range of Ctrl and CH demonstrates control cells migrated a larger distance from the website of transplant in a few embryos evenly obtained. elife-21114-fig7-data1.xlsx (39K) DOI:?10.7554\/eLife.21114.025 Figure 7figure complement 1source data 1: Raw data of Figure 7figure complement 1 Tabs 1: Raw data of Figure.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1. health supplement 1A. Tabs2: Statistical data of Shape 3figure health supplement 1B. elife-21114-fig3-figsupp1-data1.xlsx (39K) DOI:?10.7554\/eLife.21114.010 Figure 4source data 1: Natural data and statistical data of Figure 4. Tabs <a href=\"https:\/\/eurosoi.org\/?p=16\" class=\"btn btn-link continue-link\">Continue Reading<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-16","post","type-post","status-publish","format-standard","hentry","category-ligases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1 - JAK2 inhibitor against human prostate cancer cells<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurosoi.org\/?p=16\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1 - JAK2 inhibitor against human prostate cancer cells\" \/>\n<meta property=\"og:description\" content=\"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1. health supplement 1A. Tabs2: Statistical data of Shape 3figure health supplement 1B. elife-21114-fig3-figsupp1-data1.xlsx (39K) DOI:?10.7554\/eLife.21114.010 Figure 4source data 1: Natural data and statistical data of Figure 4. Tabs Continue Reading\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurosoi.org\/?p=16\" \/>\n<meta property=\"og:site_name\" content=\"JAK2 inhibitor against human prostate cancer cells\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-23T09:30:09+00:00\" \/>\n<meta name=\"author\" content=\"info\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=16#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=16\"},\"author\":{\"name\":\"info\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\"},\"headline\":\"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1\",\"datePublished\":\"2021-05-23T09:30:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=16\"},\"wordCount\":643,\"articleSection\":[\"Ligases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=16\",\"url\":\"https:\\\/\\\/eurosoi.org\\\/?p=16\",\"name\":\"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1 - JAK2 inhibitor against human prostate cancer cells\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#website\"},\"datePublished\":\"2021-05-23T09:30:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=16#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurosoi.org\\\/?p=16\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=16#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurosoi.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#website\",\"url\":\"https:\\\/\\\/eurosoi.org\\\/\",\"name\":\"JAK2 inhibitor against human prostate cancer cells\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurosoi.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\",\"name\":\"info\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"caption\":\"info\"},\"sameAs\":[\"http:\\\/\\\/eurosoi.org\"],\"url\":\"https:\\\/\\\/eurosoi.org\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1 - JAK2 inhibitor against human prostate cancer cells","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurosoi.org\/?p=16","og_locale":"en_US","og_type":"article","og_title":"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1 - JAK2 inhibitor against human prostate cancer cells","og_description":"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1. health supplement 1A. Tabs2: Statistical data of Shape 3figure health supplement 1B. elife-21114-fig3-figsupp1-data1.xlsx (39K) DOI:?10.7554\/eLife.21114.010 Figure 4source data 1: Natural data and statistical data of Figure 4. Tabs Continue Reading","og_url":"https:\/\/eurosoi.org\/?p=16","og_site_name":"JAK2 inhibitor against human prostate cancer cells","article_published_time":"2021-05-23T09:30:09+00:00","author":"info","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurosoi.org\/?p=16#article","isPartOf":{"@id":"https:\/\/eurosoi.org\/?p=16"},"author":{"name":"info","@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd"},"headline":"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1","datePublished":"2021-05-23T09:30:09+00:00","mainEntityOfPage":{"@id":"https:\/\/eurosoi.org\/?p=16"},"wordCount":643,"articleSection":["Ligases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurosoi.org\/?p=16","url":"https:\/\/eurosoi.org\/?p=16","name":"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1 - JAK2 inhibitor against human prostate cancer cells","isPartOf":{"@id":"https:\/\/eurosoi.org\/#website"},"datePublished":"2021-05-23T09:30:09+00:00","author":{"@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd"},"breadcrumb":{"@id":"https:\/\/eurosoi.org\/?p=16#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurosoi.org\/?p=16"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eurosoi.org\/?p=16#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurosoi.org\/"},{"@type":"ListItem","position":2,"name":"\ufeffSupplementary MaterialsFigure 1source data 1: Features and phenotypes from the enrolled CHARGE individuals, and uncooked data and statistical data of Shape 1"}]},{"@type":"WebSite","@id":"https:\/\/eurosoi.org\/#website","url":"https:\/\/eurosoi.org\/","name":"JAK2 inhibitor against human prostate cancer cells","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurosoi.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd","name":"info","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","caption":"info"},"sameAs":["http:\/\/eurosoi.org"],"url":"https:\/\/eurosoi.org\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/16","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16"}],"version-history":[{"count":1,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/16\/revisions"}],"predecessor-version":[{"id":17,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/16\/revisions\/17"}],"wp:attachment":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}